Related Experiment Video
Updated: Aug 21, 2026
Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing
Published on: March 19, 2013
New cellular and molecular approaches for the treatment of cardiac disease
Laurence Kedes1, Robert Kloner, Kimi Kong
1Institute of Genetic Medicine, Keck School of Medicine, Los Angeles, CA 90033, USA. kedes@usc.edu
Insights
End-stage heart failure, a common outcome of various diseases, involves complex cellular and molecular mechanisms. Interdisciplinary research between organ physiologists and molecular biologists is crucial for advancing understanding and developing new heart failure therapeutics.
Area of Science:
- Cardiology
- Molecular Biology
- Physiology
Background:
- End-stage heart failure results from diverse conditions like hypertension, inflammation, and ischemic injury.
- Understanding the cellular and molecular basis of heart failure is critical for effective treatment.
- Recent advancements in molecular genetics and cell biology offer new insights into heart failure pathophysiology.
Purpose of the Study:
- To review recent advances in understanding molecular and cellular events in heart failure.
- To explore potential new therapeutic targets for heart failure.
- To emphasize the importance of interdisciplinary collaboration in heart failure research.
Main Methods:
- Review of recent scientific literature.
- Analysis of molecular genetics and genomic data.
- Cell biology techniques.
Main Results:
- Significant progress has been made in elucidating molecular and cellular mechanisms of heart failure.
- New potential therapeutic targets have been identified.
- The critical role of interdisciplinary research is highlighted.
Conclusions:
- Investigative interactions between organ physiologists and molecular/cellular biologists accelerate understanding of heart failure.
- Collaboration is key to advancing both the pathophysiology knowledge and therapeutic strategies for heart failure.
Abstract:
Similar to the kidney in uremia, end-stage cardiac failure is an outcome common to many disparate disease processes including hypertension, various inflammatory pathologies, as well as ischemic loss of tissue. In regard to the heart, cellular and molecular mechanisms responsible for heart failure have been investigated with renewed intensity over the past several years with newer techniques of molecular genetics, genomic analysis, and cell biology. Although this article reviews some recent advances made in our understanding of molecular and cellular events in the heart leading to heart failure and explores possible new targets for therapeutics, the main point is to stress the importance of investigative interactions between organ physiologists and molecular and cellular biologists. These interactions between organ physiologists and molecular geneticists is stressed and supported as a mechanism for rapid advancement for both understanding the underlying pathophysiology of human disease and the development of therapeutic strategies.
